Effect of thymosin on herpes simplex keratitis and the change of T lymphocytes subgroup in peripheral blood;

Study on the Effect of Interferon α-2b of Different Dosages with Thymosin in Patients with Chronic Hepatitis B;

Effect of thymosin for patients with advanced non-small cell lung cancer (NSCLC) in chemotherapy;

The Auxiliary treatment for bronchiolitis with thymic peptide and interferon.;

The effects of thymic peptide α1 on T lymphocyte subsets of hepatoma patient during perioperative period;

The Clinical Analysis of 25 Chronic Hepatitis B Patients Treated with Lamivudine and Thymic Peptide;

A preliminary study of HL-60 cell DNA damage induced by thymopeptide from neonatal calf;

Preparation and release characteristics in vitro of thymopeptide gelatin microspheres;

Analysis of the Contents of Zn, Cu, Fe, Mn, Co and Ni in Thymopeptide and Transfer Factor Biological Injections;

Observation on the effect of α-2b interferon and ribavirin and thymus peptide joint treatment for the 30 patients with chronic hepatitis C.;

Thymus peptide had a better clinical curative effect,which was remarkable than that by conven.

Objective: To investigate the differences in different methods of peptide assay in thymus peptide solution and its preparation.

Preparation and characterization of Thymopentin loaded trimethyl chitosan submicron;

Preparation and quality control of thymopentin nasal spray;

Preparation and physical characterization of polylactic-co-glycolic acid nanoparticles loaded with thymopentin for oral administration;

Efficiency of thymosinα1 combined with Kushensu on treating chronic hepatitis B with iamivudine resistance.;

AIM:To prepare and evaluate the in vitro release characteristics of thymosinα1 tablet(Tα1 tablet).

The absorption of thymosinα1 in rat colon and enhancement effect of different absorption enhancers or protease inhibitor (sodium desoxycholate, Carbomer 940, water-soluble chitosan and bacitracin) were investigated using in situ perfusion method.